[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341351-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341351-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tgf-signaling-critical-nexus-of-fibrogenesis-and-cancer","TGF-β signaling: critical nexus of fibrogenesis and cancer","","TGF-β signaling is a key regulator of cell proliferation, differentiation, apoptosis, and extracellular matrix production. It operates via canonical SMAD-mediated signaling and multiple noncanonical routes including MAPK, PI3K/AKT, Rho-like GTPases, and NF-κB. The pathway is coordinated through interactions between canonical and noncanonical processes and influences normal tissue homeostasis as well as fibrosis and cancer progression. TGF-β also shows paradoxical effects: tumor suppression in physiologic settings versus promotion of inflammation-driven remodeling, tumor development, fibrosis, and future theranostic targeting potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tgf-signaling-critical-nexus-of-fibrogenesis-and-cancer/341351/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tgf-signaling-critical-nexus-of-fibrogenesis-and-cancer/341351.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biological processes does TGF-β signaling regulate?","Question",{"text":63,"@type":64},"TGF-β signaling regulates cell proliferation, differentiation, apoptosis, and extracellular matrix production, acting through both canonical and noncanonical pathways.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does canonical TGF-β signaling work?",{"text":68,"@type":64},"Canonical signaling begins when TGF-β binds type I and type II serine/threonine kinase receptors, leading to SMAD phosphorylation, formation of SMAD complexes, nuclear translocation, and regulation of target gene transcription.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is TGF-β signaling described as having paradoxical roles?",{"text":72,"@type":64},"Under normal physiologic conditions, TGF-β promotes quiescence and apoptosis as a tumor suppressor, while in pathological contexts such as inflammation and cancer it promotes remodeling and processes that facilitate tumor development and fibrosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341351,1790465240,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Giarratana et al.  \nJournal of Translational Medicine (2024) 22:594 [https://doi.org/10.1186/s12967-024-05411-4](https://doi.org/10.1186/s12967-024-05411-4)  \nJournal of Translational Medicine  \n REVIEW Open Access  \nTGF-β signaling: critical nexus offibrogenesis and cancer  \nAnna O. Giarratana 1* , Conor M. Prendergast2, Mary M. Salvatore3 and Kathleen M. Capaccione3  \nAbstract  \nThe transforming growth factor-beta (TGF-β) signaling pathway is a vital regulator of cell proliferation, differentiation, apoptosis, and extracellular matrix production. It functions through canonical SMAD-mediated processes and noncanonical pathways involving MAPK cascades, PI3K/AKT, Rho-like GTPases, and NF-κB signaling. This intricate signaling system is finely tuned by interactions between canonical and noncanonical pathways and plays key roles in both physiologic and pathologic conditions including tissue homeostasis, fibrosis, and cancer progression. TGF-β signaling is known to have paradoxical actions. Under normal physiologic conditions, TGF-β signaling promotes cell quiescence and apoptosis, acting as a tumor suppressor. In contrast, in pathological states such as inflammation and cancer, it triggers processes that facilitate cancer progression and tissue remodeling, thus promoting tumor development and fibrosis. Here, we detail the role that TGF-β plays in cancer and fibrosis and highlight the potential for future theranostics targeting this pathway.  \nKeywords TGF-β, Cell signaling, Fibrosis, Cancer, Theranostics, Precision medicine  \nBackground  \nThe role ofTGF‑β signaling  \nIn cellular biology, transforming growth factor-beta (TGF-β) signaling emerges as a crucial modulator of cell fate, orchestrating processes from cell proliferation to apoptosis. In this review, we aim to dissect the dual roles of TGF-β signaling in both fibrosis and cancer, elucidating its paradoxical behavior across different cellular contexts. We hope to integrate both established knowledge and recent findings to enhance our understanding of the full role that TGF-β signaling plays. In addition to discussing what has been discovered about TGF-β signaling, we also aim to identify potential therapeutic targets  \n*Correspondence:  \nAnna O. Giarratana [agiarratana@northwell.edu](agiarratana@northwell.edu)  \n1 Northwell Health – Peconic Bay Medical Center, 1 Heroes Way, Riverhead, NY 11901, USA  \n2 New York Medical College, Valhalla, NY 10595, USA  \n3 Department of Radiology, Columbia University, New York, NY 11032, USA  \nwithin these pathways. These targets may play a significant role in the future of medical therapies for both cancer and fibrosis. The overarching aim of our review is to summarize the existing knowledge of TGF-β signaling and to clarify how this understanding guides our identification of potential therapeutic targets.  \nTGF‑β signal transduction  \nThe TGF-β signaling pathway is a crucial regulator of numerous cellular processes including proliferation, differentiation, apoptosis, and extracellular matrix production [1]. In humans, the TGF-β superfamily is comprised of over 30 related cytokines, which act in a contextdependent manner [2]. These signal transduction pathways play an important role in both normal physiology and pathophysiology with actions in tissue homeostasis, fibrosis, and cancer progression [3].  \nThe canonical TGF-β signaling cascade is initiated by the binding of TGF-β ligands to cytoplasmic serine/ threonine kinase receptors to form a heteromeric complex. TGF-β binds the type I receptor (TβRI), which then recruits the type II (TβRII) receptor via phosphorylation.  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes wer","cbCaisAma6mRrVDr","https://ap.wps.com/l/cbCaisAma6mRrVDr","pdf",1511976,16,"English","# Abstract\n# Background\n## The role of TGF-β signaling\n## TGF-β signal transduction\n# Canonical TGF-β signaling cascade","[{\"question\":\"What biological processes does TGF-β signaling regulate?\",\"answer\":\"TGF-β signaling regulates cell proliferation, differentiation, apoptosis, and extracellular matrix production, acting through both canonical and noncanonical pathways.\"},{\"question\":\"How does canonical TGF-β signaling work?\",\"answer\":\"Canonical signaling begins when TGF-β binds type I and type II serine/threonine kinase receptors, leading to SMAD phosphorylation, formation of SMAD complexes, nuclear translocation, and regulation of target gene transcription.\"},{\"question\":\"Why is TGF-β signaling described as having paradoxical roles?\",\"answer\":\"Under normal physiologic conditions, TGF-β promotes quiescence and apoptosis as a tumor suppressor, while in pathological contexts such as inflammation and cancer it promotes remodeling and processes that facilitate tumor development and fibrosis.\"}]","TGF-β signaling: critical nexus of fibrogenesis and cancer | PDF",1790041631,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55f494ac2b8d1743bbf13279af76dc0f.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdd1d75105b7fc1349405443a2c53f46.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d75dcf72d5f65ecbd73e6fe6adc4569.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/314dccba528418053929089445e9c20e.webp",980,1301]